Sfoglia per AUTORE
KURUVILLA J
Collezione AOU Città della Salute di Torino
Items : 2
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma. in EJHaem / EJHaem. 2022 Feb 14;3(2):394-405. doi: 10.1002/jha2.394. eCollection 2022 May.
2022
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Hagner P; Li Y; Sangha R; Shen F; Greenwald DR; Klein LM; Isufi I; Andorsky DJ; Corradini P; Kenkre VP; Boccomini C; Flinn IW; Santoro A; Witzig TE; Bijou F; Chavez JC; Kuruvilla J; Nastoupil LJ; Dobmeyer J; Gong N; Uttamsingh S; Pourdehnad M; Ribrag V;
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study. in Cancers / Cancers (Basel). 2022 Feb 4;14(3):791. doi: 10.3390/cancers14030791.
2022
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Zijlstra JM; Follows G; Casasnovas RO; Vermaat JSP; Kalakonda N; Choquet S; Hill B; Thieblemont C; Cavallo F; Cruz F; Kuruvilla J; Hamad N; Jaeger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vassilakopoulos TP; Samal P; Ku M; Xu J; Corona K; Chamoun K; Shah J; Canales M; et alii...